Russian company claums drug for Covid-19 cure
The R-Pharm Group focuses on research, development, manufacturing and commercialization of pharmaceuticals, laboratory equipment and medical devices.
By IAR Desk
According to a report by Russian news agency TASS, the Koronavir drug for the treatment of the novel coronavirus, has been released in Russia. R-Pharm, the company making the drug has said in a public statement on Wednesday, July 15. The drug was produced and labeled at its factory in the city of Yaroslavl as noted by the company. The report cited the statement “To date 7,373 drug packages have been put in civil circulation”.
Meanwhile, R-Pharm’s press service stated that “Koronavir is one of the first drugs in the world that fights not the complications from SARS-CoV-2, but directly the virus itself”. According to the company, Koronavir effectively blocks the replication of the virus, which was proved during clinical tests.
The report also cited a statement by an official as saying “The Russian manufacturer marks its drug with the Data Matrix digital code. The labeling is an analogue of the drug’s passport, it guarantees its authenticity and allows you to track the movement of each package: from production to delivery to a medical facility. Authenticity can be checked using the Chestny Znak mobile application”. It was also mentioned that under a decree of the Russian government, drug labeling is mandatory in Russia since July 1.
R-Pharm Group focuses on research, development, manufacturing and commercialization of pharmaceuticals, laboratory equipment and medical devices. The company founded in 2001 operates in Russia, as well as in CIS states, the US, Germany, Japan and other countries.
